Heartbeam (BEAT) vs Mangoceuticals (MGRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Heartbeam is the larger company by market cap ($27.5 million vs $9.3 million), about 3.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BEAT | MGRX |
|---|---|---|
| Share price | $0.4887 | $0.4324 |
| Market cap | $27.54M | $9.33M |
| 1-day change | -10.00% | -2.55% |
| YTD return | -79.64% | — |
| 1-year return | -72.85% | — |
| EPS (TTM) | $-0.50 | $-1.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.00 | $2.75 |
| 52-week low | $0.355 | $0.162 |
| Distance from 52-week high | -87.78% | -84.28% |
| Analyst consensus | buy | — |
| Avg. price target upside | +616.19% | — |
| Average volume | 7.37M | 12.84M |
| Shares outstanding | 56.35M | 21.57M |
| Employees | 16 | 3 |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Health Information Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Heartbeam is about 3.0 times larger than Mangoceuticals by market value ($27.54M vs $9.33M).
About Heartbeam
BEAT stock →HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility.
Healthcare · Health Information Services · 16 employees
About Mangoceuticals
MGRX stock →Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States.
Healthcare · Health Information Services · 3 employees
BEAT vs MGRX FAQ
Which is bigger, Heartbeam or Mangoceuticals?
Heartbeam (BEAT) is larger, with a market capitalization of $27.54M compared with $9.33M for Mangoceuticals (MGRX).
Are Heartbeam and Mangoceuticals in the same industry?
Yes. Both are classified in the Health Information Services industry within the Healthcare sector.